Concepts (191)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burnout, Professional | 1 | 2023 | 131 | 0.700 |
Why?
|
| Extracellular Vesicles | 4 | 2023 | 67 | 0.500 |
Why?
|
| Computational Biology | 2 | 2026 | 875 | 0.320 |
Why?
|
| Software | 3 | 2026 | 754 | 0.220 |
Why?
|
| Workflow | 1 | 2025 | 140 | 0.210 |
Why?
|
| RNA | 4 | 2023 | 530 | 0.200 |
Why?
|
| Radiology, Interventional | 1 | 2023 | 35 | 0.200 |
Why?
|
| Gene Regulatory Networks | 1 | 2026 | 379 | 0.200 |
Why?
|
| Radiologists | 1 | 2023 | 54 | 0.200 |
Why?
|
| Exosomes | 1 | 2023 | 62 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 1989 | 495 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 1993 | 57 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2019 | 59 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1009 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 49 | 0.160 |
Why?
|
| Thymus Gland | 5 | 1993 | 101 | 0.160 |
Why?
|
| Genetic Variation | 2 | 2026 | 1577 | 0.150 |
Why?
|
| Cell Communication | 1 | 2019 | 190 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1851 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2020 | 530 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2020 | 346 | 0.120 |
Why?
|
| Pandemics | 1 | 2023 | 1168 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2020 | 901 | 0.120 |
Why?
|
| Spine | 1 | 2016 | 146 | 0.120 |
Why?
|
| Epigenomics | 1 | 2016 | 182 | 0.120 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 1399 | 0.110 |
Why?
|
| Glioma | 1 | 2020 | 504 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 390 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 1965 | 0.100 |
Why?
|
| Hypoxia | 2 | 2005 | 246 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2023 | 4078 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 1992 | 1488 | 0.100 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1991 | 1 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 3 | 0.090 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 10 | 0.090 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 1706 | 0.090 |
Why?
|
| RNA, Messenger | 7 | 2004 | 2585 | 0.090 |
Why?
|
| Base Sequence | 8 | 1994 | 2784 | 0.080 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1989 | 4 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2005 | 424 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 1994 | 3532 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1989 | 73 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 1 | 1988 | 51 | 0.070 |
Why?
|
| Humans | 14 | 2026 | 132158 | 0.070 |
Why?
|
| Trans-Activators | 3 | 1997 | 692 | 0.070 |
Why?
|
| United States | 1 | 2023 | 11867 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3253 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 31755 | 0.060 |
Why?
|
| Quality of Life | 1 | 2016 | 2117 | 0.060 |
Why?
|
| Transcription Factors | 5 | 2004 | 2462 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1992 | 787 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 6 | 1994 | 985 | 0.060 |
Why?
|
| Mice | 12 | 2004 | 18397 | 0.060 |
Why?
|
| DNA Repair | 2 | 2005 | 585 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 1746 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2004 | 1221 | 0.050 |
Why?
|
| DNA Restriction Enzymes | 1 | 2004 | 73 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 56 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 2031 | 0.050 |
Why?
|
| Galactose | 1 | 2004 | 53 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2025 | 164 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2658 | 0.050 |
Why?
|
| Muscles | 1 | 2004 | 220 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 164 | 0.050 |
Why?
|
| Male | 7 | 2023 | 65464 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 436 | 0.050 |
Why?
|
| Databases, Genetic | 1 | 2026 | 504 | 0.050 |
Why?
|
| Female | 6 | 2023 | 71430 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 324 | 0.050 |
Why?
|
| Animals | 14 | 2004 | 34288 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 2994 | 0.050 |
Why?
|
| Internet | 1 | 2025 | 421 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 3426 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1235 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 405 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 612 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2004 | 752 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2023 | 291 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 76 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 11 | 0.040 |
Why?
|
| Gene Expression | 3 | 1999 | 1508 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 40 | 0.040 |
Why?
|
| Body Fluids | 1 | 2019 | 46 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 234 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2000 | 259 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 329 | 0.030 |
Why?
|
| Zinc Fingers | 2 | 1997 | 119 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 2358 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 1003 | 0.030 |
Why?
|
| Placental Lactogen | 1 | 1997 | 2 | 0.030 |
Why?
|
| Nervous System | 2 | 1995 | 123 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 1690 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 140 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 421 | 0.030 |
Why?
|
| Trophoblasts | 1 | 1997 | 118 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 1993 | 6 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1995 | 8 | 0.030 |
Why?
|
| Disease Progression | 2 | 2016 | 2230 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 432 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 87 | 0.030 |
Why?
|
| Transfection | 3 | 2005 | 960 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1997 | 1006 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 266 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 314 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 171 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3714 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1999 | 1230 | 0.030 |
Why?
|
| Aging | 2 | 1992 | 1274 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2026 | 1908 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1995 | 135 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 351 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 495 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 681 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2005 | 599 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 253 | 0.020 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1992 | 1 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 31 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 703 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1989 | 275 | 0.020 |
Why?
|
| Point Mutation | 1 | 1992 | 339 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 3 | 1997 | 45 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 308 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 97 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 257 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2000 | 2947 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 1102 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 977 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 59 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1066 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 367 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 1805 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 1304 | 0.020 |
Why?
|
| Cell Line | 2 | 1989 | 2591 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4550 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 2 | 1997 | 46 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2005 | 32 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 127 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 221 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 452 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 95 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 3459 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1441 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 777 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 659 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 10126 | 0.010 |
Why?
|
| Iron | 1 | 2004 | 308 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 260 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2000 | 32 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 99 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 13017 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 236 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 240 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2000 | 236 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1999 | 118 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1226 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17763 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 694 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 21018 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 590 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 35 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 112 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1146 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1427 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2000 | 782 | 0.010 |
Why?
|
| Litter Size | 1 | 1995 | 24 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 76 | 0.010 |
Why?
|
| Craniofacial Dysostosis | 1 | 1995 | 25 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 294 | 0.010 |
Why?
|
| Fetal Death | 1 | 1995 | 120 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 348 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2144 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 54 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 121 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1614 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 450 | 0.010 |
Why?
|
| Cell Movement | 1 | 1997 | 882 | 0.010 |
Why?
|
| Placenta | 1 | 1997 | 526 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 588 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1995 | 380 | 0.010 |
Why?
|
| Gestational Age | 1 | 1995 | 1237 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1995 | 550 | 0.010 |
Why?
|
| Genotype | 1 | 1995 | 2654 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 2367 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1989 | 131 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2421 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1995 | 3864 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 4734 | 0.000 |
Why?
|
| Mutation | 1 | 1997 | 6206 | 0.000 |
Why?
|